Chemicals Press Releases
SEE OTHER BRANDS

Following the chemical industry news from the world

24/7 Market News: Kraig Labs Prepares for High-Profile International Order as Second Production Facility Reaches Full Operational Status

Specialized Spider Silk to Fulfill Demand from Iconic Global Brand, Expectations Soar for Q4 Ramp-Up

DENVER, Aug. 27, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the global leader in spider silk-based super fiber technologies, opened its second Southeast Asian production rearing center, which is now fully operational, just as the Company prepares to fulfill a specialized silk order for a prestigious international brand.

This timing couldn’t be more strategic. With both rearing centers online, Kraig Labs now possesses the parallel capacity to support continuous breeding cycles, maximize output, and ensure consistent supply of its next-generation BAM-1 hybrid silk just as demand begins to materialize on the commercial front.

Kraig’s upcoming order is for a very special silk product, custom-developed in collaboration with one of the most well-known global brands in high-performance textiles and represents the culmination of over a decade of research and a massive leap toward full commercial integration.

Building Momentum, Meeting Demand

The second facility expands the Company’s breeding program beyond the core BAM-1 line to include three new genetic parental strains introduced earlier this summer. This diversification is expected to accelerate production efficiencies and improve fiber quality consistency, two critical components of scaling for volume and reliability.

The dual-facility model also provides built-in redundancy to avoid past production bottlenecks, allowing Kraig Labs to operate rearing and cocoon harvesting on a rolling basis a key requirement to meet growing interest from military, apparel, and high-performance fabric partners.

A Super Fiber, Ready for Market

Kraig’s spider silk is known for being stronger than steel, tougher than Kevlar, and fully biodegradable, with a near-perfect ESG profile. While several competitors attempted to commercialize synthetic silk fibers over the past decade, few have overcome the cost, scalability, and chemical processing barriers. The Company’s natural, infrastructure-based approach now appears poised to succeed where others have failed.

What Comes Next

Kraig Labs is currently finalizing logistics and quality verification for the initial commercial delivery of this special silk variant and could announce additional orders from global textile leaders in Q4. With both rearing centers fully active and production scaling, Kraig Labs is now firmly positioned to begin capturing market share in the multibillion-dollar technical fibers sector.

Please click here for most recent CEO letter to shareholders.

Please click here to read the full Kraig Labs analyst report on 247marketnews.com.

For more information, please visit: www.kraiglabs.com

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) is a biotechnology company focused on the development and commercialization of spider silk-based fiber technologies. Through its proprietary silkworm-based genetic engineering platform, Kraig Labs produces high-performance, cost-effective, and scalable spider silk materials for use in defense, performance apparel, technical textiles, and medical applications.

Contact sales@247marketnews.com for Analyst Report coverage and other investor/public relations services.

24/7 MARKET NEWS, INC Disclaimer

Please go to https://247marketnews.com/kblb-disclosure/ for disclaimer information.

About 24/7 Market News

24/7 Market News is a leading platform for public company market news. As a pioneer in digital media, we are committed to the rapid dissemination of financial market news and information. We excel in creating innovative public relations campaigns to help our clients effectively reach their target audience. 24/7 Market News offers paid coverage for public companies. For more information or PR inquiries, please contact: sales@247marketnews.com

Please go to www.247marketnews.com for further information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Actual results could differ materially from those described in these forward-looking statements due to a number of factors, including without limitation, the Company's ability to continue as a going concern, the popularity and/or competitive success of the Company's acquired football and other sports teams, the Company's ability to attract players and staff for acquired clubs, unsuccessful acquisitions or other strategic transactions, the possibility of a decline in the popularity of football or other sports, the Company's ability to expand its fanbase, sponsors and commercial partners, general economic conditions, and other risk factors detailed in the Company's filings with the SEC. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update such forward-looking statements except in accordance with applicable law.


Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions